Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice

Publication Date: September 1, 2019
Last Updated: December 15, 2022

Diagnosis

Table 2. Recommendations

Invasive fungal disease

In patients with severe immune compromise, such as those with neutropenia, hematologic malignancy or recipients of hematologic stem cell or solid organ transplants presenting with unexplained lung infiltrates suspected of invasive fungal disease, the ATS recommends the use of serum GM testing. (S, H)
620

Overview

Title

Microbiological Laboratory Testing in the Diagnosis of Fungal Infections in Pulmonary and Critical Care Practice

Authoring Organization